Finally, it should be highlighted that USP22 also targets additional substrates beyond H2Bub1, including SIRT1, FBP1 and Cyclin D1 (reviewed in [76]), and thus it will be important to establish whether they also impact CIN. This evidence concerns the gene SIRT1 and cervical squamous intraepithelial neoplasia.